Terms: = Gastric cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
27 results:
1. [Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].
Liu S; Xia QY; Fu Y; Lu XF; Wang M; Guan WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):675-679. PubMed ID: 37583025
[No Abstract] [Full Text] [Related]
2. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
3. Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns.
Sentani K; Imai T; Kobayashi G; Hayashi T; Sasaki N; Oue N; Yasui W
Gastric Cancer; 2021 Mar; 24(2):368-381. PubMed ID: 33118117
[TBL] [Abstract] [Full Text] [Related]
4. Methylation-induced silencing of SPG20 facilitates gastric cancer cell proliferation by activating the egfr/MAPK pathway.
Zhou Z; Wang W; Xie X; Song Y; Dang C; Zhang H
Biochem Biophys Res Commun; 2018 Jun; 500(2):411-417. PubMed ID: 29673586
[TBL] [Abstract] [Full Text] [Related]
5. Recent insights in the therapeutic management of patients with gastric cancer.
de Mestier L; Lardière-Deguelte S; Volet J; Kianmanesh R; Bouché O
Dig Liver Dis; 2016 Sep; 48(9):984-94. PubMed ID: 27156069
[TBL] [Abstract] [Full Text] [Related]
6. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer.
Yamashita K; Hosoda K; Ema A; Watanabe M
Eur J Surg Oncol; 2016 Sep; 42(9):1253-60. PubMed ID: 27017273
[TBL] [Abstract] [Full Text] [Related]
7. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.
Li L; Jiang X; Zhang Q; Dong X; Gao Y; He Y; Qiao H; Xie F; Xie X; Sun X
J Exp Clin Cancer Res; 2016 Jan; 35():16. PubMed ID: 26795388
[TBL] [Abstract] [Full Text] [Related]
8. Investigation of erbb-2 overexpression on patients with gastric cancer in Eastern Anatolia of Turkey.
Emre H; Tekin SB; Doğan H; Çayır K; Bilici M; Sipal S; Pirim I
Turk J Gastroenterol; 2013; 24(3):211-7. PubMed ID: 24226713
[TBL] [Abstract] [Full Text] [Related]
9. Relationship between expression of egfr in gastric cancer tissue and clinicopathological features.
Gao M; Liang XJ; Zhang ZS; Ma W; Chang ZW; Zhang MZ
Asian Pac J Trop Med; 2013 Apr; 6(4):260-4. PubMed ID: 23608326
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract] [Full Text] [Related]
11. Current developments in the management of locally advanced esophageal cancer.
McNamara MJ; Adelstein DJ
Curr Oncol Rep; 2012 Aug; 14(4):342-9. PubMed ID: 22544559
[TBL] [Abstract] [Full Text] [Related]
12. Tumor size predicts survival in mucinous gastric carcinoma.
Sung CO; Lee SM; Choi JS; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim WH; Park CK; Kim S
J Surg Oncol; 2012 Nov; 106(6):757-64. PubMed ID: 22535583
[TBL] [Abstract] [Full Text] [Related]
13. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
14. [Expression and clinical significance of epidermal growth factor receptor and protein kinase B in gastric carcinoma].
Zhang HY; Tao HM; Chen HT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):140-2. PubMed ID: 21365510
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of p73 as a tissue marker for high-risk gastritis.
Carrasco G; Diaz J; Valbuena JR; Ibanez P; Rodriguez P; Araya G; Rodriguez C; Torres J; Duarte I; Aravena E; Mena F; Barrientos C; Corvalan AH
Clin Cancer Res; 2010 Jun; 16(12):3253-9. PubMed ID: 20530692
[TBL] [Abstract] [Full Text] [Related]
16. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
[TBL] [Abstract] [Full Text] [Related]
17. [Differential expression of immunohistochemical markers between cardiac carcinoma and carcinoma in antrum of stomach and correlation thereof with clinicopathological factors].
Ye YW; Shi YQ; Wang CM; Li BZ; Zhu L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):962-6. PubMed ID: 19671307
[TBL] [Abstract] [Full Text] [Related]
18. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract] [Full Text] [Related]
19. Epidermal growth factor receptor (egfr) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.
Galizia G; Lieto E; Orditura M; Castellano P; Mura AL; Imperatore V; Pinto M; Zamboli A; De Vita F; Ferraraccio F
World J Surg; 2007 Jul; 31(7):1458-68. PubMed ID: 17516110
[TBL] [Abstract] [Full Text] [Related]
20. [Immunohistochemical study of p53, c-erbb-2 and nm23 proteins in human gastric cancer].
Wei Z; Wu Y; Zhai Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
[TBL] [Abstract] [Full Text] [Related]
[Next]
